Pharmacoeconomic Evaluation of Antidiabetic Medication in Geriatric Type 2 Diabetes- A Brief Study

Simple item page
dc.contributor.authorJakhar, Aen_US
dc.contributor.authorHussain, Sen_US
dc.contributor.authorHussain, MSen_US
dc.contributor.authorSaifi, Len_US
dc.contributor.authorUsman, Ken_US
dc.contributor.authorSawlani, KKen_US
dc.contributor.authorKhattri, S.en_US
dc.date.accessioned2025-05-14T09:32:52Z
dc.date.available2025-05-14T09:32:52Z
dc.date.issued2024-12
dc.description.abstractIntroduction: Diabetes mellitus (DM) is a long-term condition that poses an enormous health and economic burden on society. Unfortunately, there is a dearth of such evidence in India. Hence, we sought to estimate the direct cost of antidiabetic medication in the geriatric population. Aim and Objectives: The aim of this study is to evaluate the pharmacoeconomic of antidiabetic medication in geriat- ric type 2 diabetes mellitus patients attending outpatient department in a tertiary care teaching hospital. Materials and Methods: The demographic characteristics, clinical characteristics, and treatment profiles of patients were compiled. All diabetic patients who visited an outpatient department had their prescriptions recorded. A pharma- coeconomic analysis of prescribed anti-diabetic medications was conducted. Results: The study enrolled 600 DM patients, of which 67.83% were males, 32.17 % were females, and the pre- dominant age group was 60–64 years. In 94.54% of patients, the most frequently prescribed antidiabetic drug was metformin 500 mg. In 39.31% of patients, the most frequently prescribed antidiabetic combination was glimepiride 2 mg + metformin 500 mg. Insulin was prescribed in 14.83% of the cases. The percentage cost difference for diabetes medications ranges from 43.010 to 644.444. The monthly cost of monotherapy for most patients with controlled diabe- tes (31.46%) and uncontrolled diabetes (42.12%) was between 500 and 1000 INR. In addition, the cost of combination therapy ranges between INR 118.91 and INR 300.27. Conclusion: The costs associated with diabetes are immense and impose a substantial burden on society. Consequent- ly, policymakers should prioritize preventing the disease and its associated problems.en_US
dc.identifier.affiliationsDepartment of Pharmacology & Therapeutics, King George’s Medical University, Lucknow, Uttar Pradesh, Indiaen_US
dc.identifier.affiliationsDepartment of Pharmacology, All India Institute of Medical Sciences, Jammu, Jammu & Kashmir, Indiaen_US
dc.identifier.affiliationsDepartment of Pharmacology & Therapeutics, King George’s Medical University, Lucknow, Uttar Pradesh, Indiaen_US
dc.identifier.affiliationsDepartment of Pharmacology & Therapeutics, King George’s Medical University, Lucknow, Uttar Pradesh, Indiaen_US
dc.identifier.affiliationsDepartment of Medicine, King George’s Medical University, Lucknow, Uttar Pradesh, Indiaen_US
dc.identifier.affiliationsDepartment of Medicine, King George’s Medical University, Lucknow, Uttar Pradesh, Indiaen_US
dc.identifier.affiliationsDepartment of Pharmacology & Therapeutics, King George’s Medical University, Lucknow, Uttar Pradesh, Indiaen_US
dc.identifier.citationJakhar A, Hussain S, Hussain MS, Saifi L, Usman K, Sawlani KK, Khattri S.. Pharmacoeconomic Evaluation of Antidiabetic Medication in Geriatric Type 2 Diabetes- A Brief Study . National Journal of Physiology, Pharmacy and Pharmacology. 2024 Dec; 14(12): 2617-2626en_US
dc.identifier.issn2231-3206
dc.identifier.issn2320-4672
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/247841
dc.languageenen_US
dc.publisher?Eldaghayes Publisheren_US
dc.relation.issuenumber12en_US
dc.relation.volume14en_US
dc.source.urihttps://doi.org/10.5455/NJPPP.2024.v14.i12.21en_US
dc.subjectPharmacoeconomicen_US
dc.subjectDrug utilizationen_US
dc.subjectAntidiabetic drugen_US
dc.subjectDiabetes mellitusen_US
dc.subjectGlimepirideen_US
dc.subjectMetforminen_US
dc.titlePharmacoeconomic Evaluation of Antidiabetic Medication in Geriatric Type 2 Diabetes- A Brief Studyen_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
njppp2024v14n12p2617.pdf
Size:
890.22 KB
Format:
Adobe Portable Document Format
Download
Collections
National Journal of Physiology, Pharmacy and Pharmacology